Shobhit is the Fund Manager of Oncode Oncology Bridge Fund where he creates and invests in early stage oncology focused companies. He currently holds board roles and led investments in Flindr Therapeutics (formerly Immagene) and sCellgen. Prior to joining Oncode Bridge Fund, he was an early stage investor at UvA/AMC Ventures for 4 years, where he made investments in tech and life science spin offs from the two institutions. He trained as a pharmacologist at the University of Oxford and started his drug discovery career at Pfizer UK. Shobhit holds a PhD in immunology from the University of Amsterdam.